1. Home
  2. JFIN vs DNA Comparison

JFIN vs DNA Comparison

Compare JFIN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • DNA
  • Stock Information
  • Founded
  • JFIN 2011
  • DNA 2008
  • Country
  • JFIN China
  • DNA United States
  • Employees
  • JFIN N/A
  • DNA N/A
  • Industry
  • JFIN Finance: Consumer Services
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JFIN Finance
  • DNA Health Care
  • Exchange
  • JFIN Nasdaq
  • DNA Nasdaq
  • Market Cap
  • JFIN 682.1M
  • DNA 731.1M
  • IPO Year
  • JFIN 2019
  • DNA N/A
  • Fundamental
  • Price
  • JFIN $11.60
  • DNA $11.14
  • Analyst Decision
  • JFIN
  • DNA Hold
  • Analyst Count
  • JFIN 0
  • DNA 2
  • Target Price
  • JFIN N/A
  • DNA $9.50
  • AVG Volume (30 Days)
  • JFIN 140.3K
  • DNA 1.6M
  • Earning Date
  • JFIN 08-20-2025
  • DNA 11-11-2025
  • Dividend Yield
  • JFIN 7.33%
  • DNA N/A
  • EPS Growth
  • JFIN 33.85
  • DNA N/A
  • EPS
  • JFIN 4.21
  • DNA N/A
  • Revenue
  • JFIN $908,895,698.00
  • DNA $230,815,000.00
  • Revenue This Year
  • JFIN N/A
  • DNA N/A
  • Revenue Next Year
  • JFIN N/A
  • DNA $13.73
  • P/E Ratio
  • JFIN $2.60
  • DNA N/A
  • Revenue Growth
  • JFIN 8.19
  • DNA 25.21
  • 52 Week Low
  • JFIN $5.18
  • DNA $5.00
  • 52 Week High
  • JFIN $19.23
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 50.05
  • DNA 48.29
  • Support Level
  • JFIN N/A
  • DNA $9.87
  • Resistance Level
  • JFIN $11.42
  • DNA $11.97
  • Average True Range (ATR)
  • JFIN 0.63
  • DNA 0.78
  • MACD
  • JFIN -0.40
  • DNA -0.08
  • Stochastic Oscillator
  • JFIN 84.98
  • DNA 41.06

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: